Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> VERTEX Latest News

MAY 13, 2015 - Wall Street Journal

A Must Read - Share

FDA Panel Backs Vertex Cystic-Fibrosis Drug Orkambi

Vertex Pharmaceuticals’ experimental cystic fibrosis treatment Orkambi won the backing of an FDA advisory panel, which recommended approval.

Tags: FDA Panel Backs Vertex Cystic-Fibrosis Drug Orkambi,  Vertex Latest News

MAY 12, 2015 - Yahoo! News

A Must Read - Share

FDA panel recommends Vertex cystic fibrosis treatment

By David Morgan WASHINGTON (Reuters) - A U.S. Food and Drug Administration advisory committee on Tuesday recommended approval of Vertex Pharmaceuticals Inc's combination cystic fibrosis therapy, finding it to be safe and effective for patients ages 12 and up. The recommendation, which came in a 12-1 vote, will now be considered by FDA officials who are expected to decide by ...

Tags: FDA panel recommends Vertex cystic fibrosis treatment,  Vertex Latest News

MAY 12, 2015 - Washington Times

A Must Read - Share

FDA panel backs Vertex combination pill for cystic fibrosis

WASHINGTON (AP) - Federal health advisers on Tuesday recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients. Vertex Pharmaceuticals has asked the Food and Drug Administration to approve its twice-a-day drug for patients with the ...

Tags: FDA panel backs Vertex combination pill for cystic fibrosis,  Vertex Latest News

MAY 12, 2015 - Yahoo! News

A Must Read - Share

US FDA panel recommends Vertex cystic fibrosis Orkambi treatment

WASHINGTON (Reuters) - A Food and Drug Administration advisory committee recommended approval of Vertex Pharmaceutical Inc's Orkambi treatment for cystic fibrosis, finding the combination therapy safe and effective for patients aged 12 and up. (Reporting by David Morgan; Editing by Diane Craft)

Tags: US FDA panel recommends Vertex cystic fibrosis Orkambi treatment,  Vertex Latest News

MAY 12, 2015 - Yahoo! News

A Must Read - Share

FDA panel fails to find Vertex lumacaftor positive for cystic fibrosis

WASHINGTON (Reuters) - A divided U.S. Food and Drug Administration advisory committee on Tuesday said research data does not show definitively that Vertex Pharmaceutical Inc's drug lumacaftor has a positive effect on cystic fibrosis patients when used in combination with the company's approved therapy, Kalydeco. The panel reached its decision with only three members voting in favor of efficacy. Four ...

Tags: FDA panel fails to find Vertex lumacaftor positive for cystic fibrosis,  Vertex Latest News